ARS Pharmaceuticals, Inc (SPRY) valuation · rev $84.3M
ARS Pharmaceuticals, Inc (SPRY) rev $84.3M.
| Metric | Value |
|---|---|
| Market cap | $983.1M |
| Revenue | $84.3M |
| P/S | 11.7 |
| P/B | 16.0 |
SPRY valuation FAQ
What is SPRY's market cap?
ARS Pharmaceuticals, Inc (SPRY) market cap is $983.1M on the latest cached fundamentals snapshot.
What is SPRY's latest revenue?
Latest cached ARS Pharmaceuticals, Inc (SPRY) revenue was $84.3M. Statements: https://lician.com/financials/spry
What is SPRY's price-to-sales ratio?
ARS Pharmaceuticals, Inc (SPRY) price-to-sales (P/S) is 11.7, cached market cap $983.1M divided by revenue $84.3M.
What is SPRY's price-to-book ratio?
ARS Pharmaceuticals, Inc (SPRY) price-to-book (P/B) is 16.0 on the latest cached fundamentals snapshot.
How many SPRY valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for ARS Pharmaceuticals, Inc (SPRY): Market cap, Revenue, P/S, and P/B.
Where is SPRY valuation listed?
Cached valuation multiples for ARS Pharmaceuticals, Inc (SPRY) are listed at https://lician.com/valuation/spry.
Not investment advice. Cached rows, not a live tape.